Lpl Financial LLC Exact Sciences Corp Transaction History

Lpl Financial LLC

  • $218 Billion
  • Q3 2024

A detailed history of Lpl Financial LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Lpl Financial LLC holds 80,697 shares of EXAS stock, worth $4.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80,697
Previous 79,191 1.9%
Holding current value
$4.64 Million
Previous $3.35 Million 64.25%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$42.43 - $70.83 $63,899 - $106,669
1,506 Added 1.9%
80,697 $5.49 Million
Q2 2024

Aug 07, 2024
SELL
$41.33 - $74.26 $34,882 - $62,675
-844 Reduced 1.05%
79,191 $3.35 Million
Q1 2024

May 10, 2024
SELL
$56.27 - $73.77 $263,850 - $345,907
-4,689 Reduced 5.53%
80,035 $5.53 Million
Q4 2023

Feb 14, 2024
BUY
$59.06 - $75.72 $268,604 - $344,374
4,548 Added 5.67%
84,724 $6.27 Million
Q3 2023

Nov 13, 2023
BUY
$65.94 - $99.04 $200,457 - $301,081
3,040 Added 3.94%
80,176 $5.47 Million
Q2 2023

Jul 31, 2023
SELL
$62.68 - $95.05 $343,047 - $520,208
-5,473 Reduced 6.63%
77,136 $7.24 Million
Q1 2023

May 10, 2023
BUY
$47.19 - $70.77 $155,207 - $232,762
3,289 Added 4.15%
82,609 $5.6 Million
Q4 2022

Feb 07, 2023
SELL
$30.35 - $53.15 $145,588 - $254,960
-4,797 Reduced 5.7%
79,320 $3.93 Million
Q3 2022

Nov 14, 2022
SELL
$31.97 - $49.37 $48,882 - $75,486
-1,529 Reduced 1.79%
84,117 $2.73 Million
Q2 2022

Aug 12, 2022
SELL
$35.61 - $76.23 $284,701 - $609,458
-7,995 Reduced 8.54%
85,646 $3.37 Million
Q1 2022

May 16, 2022
SELL
$57.56 - $82.54 $980,016 - $1.41 Million
-17,026 Reduced 15.38%
93,641 $6.55 Million
Q4 2021

Feb 14, 2022
BUY
$72.5 - $100.68 $421,660 - $585,554
5,816 Added 5.55%
110,667 $8.61 Million
Q3 2021

Nov 15, 2021
SELL
$90.24 - $124.05 $227,043 - $312,109
-2,516 Reduced 2.34%
104,851 $10 Million
Q2 2021

Aug 13, 2021
BUY
$93.66 - $139.27 $643,537 - $956,924
6,871 Added 6.84%
107,367 $13.3 Million
Q1 2021

May 14, 2021
SELL
$116.57 - $155.01 $42,314 - $56,268
-363 Reduced 0.36%
100,496 $13.2 Million
Q4 2020

Feb 12, 2021
BUY
$99.61 - $142.12 $103,594 - $147,804
1,040 Added 1.04%
100,859 $13.4 Million
Q3 2020

Nov 09, 2020
SELL
$72.92 - $102.01 $656,280 - $918,090
-9,000 Reduced 8.27%
99,819 $10.2 Million
Q2 2020

Aug 13, 2020
BUY
$55.75 - $92.75 $693,418 - $1.15 Million
12,438 Added 12.91%
108,819 $9.46 Million
Q1 2020

May 14, 2020
SELL
$37.9 - $104.44 $236,154 - $650,765
-6,231 Reduced 6.07%
96,381 $5.59 Million
Q4 2019

Feb 14, 2020
BUY
$77.66 - $99.74 $1.41 Million - $1.81 Million
18,191 Added 21.55%
102,612 $9.49 Million
Q3 2019

Nov 13, 2019
BUY
$90.37 - $122.49 $13,103 - $17,761
145 Added 0.17%
84,421 $7.63 Million
Q2 2019

Aug 09, 2019
BUY
$89.51 - $118.04 $354,459 - $467,438
3,960 Added 4.93%
84,276 $9.95 Million
Q1 2019

May 08, 2019
BUY
$61.98 - $96.5 $1.15 Million - $1.79 Million
18,568 Added 30.07%
80,316 $6.96 Million
Q4 2018

Feb 07, 2019
BUY
$56.04 - $82.66 $725,718 - $1.07 Million
12,950 Added 26.54%
61,748 $3.9 Million
Q3 2018

Nov 14, 2018
BUY
$48.29 - $80.6 $165,972 - $277,022
3,437 Added 7.58%
48,798 $3.85 Million
Q2 2018

Aug 14, 2018
SELL
$37.84 - $69.96 $154,084 - $284,877
-4,072 Reduced 8.24%
45,361 $2.71 Million
Q1 2018

May 15, 2018
BUY
$39.82 - $57.53 $530,521 - $766,472
13,323 Added 36.9%
49,433 $1.99 Million
Q4 2017

Feb 14, 2018
BUY
$46.49 - $60.51 $14,458 - $18,818
311 Added 0.87%
36,110 $1.9 Million
Q3 2017

Nov 14, 2017
SELL
$37.05 - $47.12 $102,295 - $130,098
-2,761 Reduced 7.16%
35,799 $1.69 Million
Q2 2017

Aug 14, 2017
BUY
N/A
38,560
38,560 $1.36 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email